anticancer peptide drugs peptide - Peptides for lung cancer anti-cancer therapeutics Anticancer Peptide Drugs: A Promising Frontier in Cancer Treatment

List ofanticancerpeptides The landscape of cancer treatment is continuously evolving, with anticancer peptide drugs emerging as a significant and promising area of research and development. These small bioactive molecules offer a unique approach to combating cancer, often complementing or even surpassing traditional therapies. Their potential lies in their targeted action, ability to overcome drug resistance, and favorable safety profiles compared to conventional chemotherapy.

Understanding Anticancer Peptides

Anticancer peptides (ACPs) are short chains of amino acids that exhibit cytotoxic or immunomodulatory effects against cancer cells. They can be derived from natural sources, such as antimicrobial peptides, or designed synthetically.Role of Anti-Cancer Peptides as Immunomodulatory Agents Unlike broad-spectrum chemotherapy, ACPs often target specific molecular features of cancer cells, such as altered cell membranes or overexpressed receptors, thereby minimizing damage to healthy tissues. This targeted approach is a key advantage, contributing to reduced side effects and improved patient quality of life.

Mechanisms of Action and Therapeutic Potential

The mechanisms by which anticancer peptide drugs exert their effects are diverse作者：A Sood·2024·被引用次数：11—There are 29peptide-baseddrugsas indrugbank database out of which 5 have been approved and 11 are still under trials (Table 2). The .... Many ACPs function by disrupting the integrity of cancer cell membranes, leading to cell death. Others can induce apoptosis (programmed cell death) through intracellular signaling pathways. Furthermore, some peptides possess immunomodulatory properties, stimulating the patient's own immune system to recognize and attack cancer cells. This dual action – direct cytotoxicity and immune enhancement – makes them particularly potent.作者：X Sun·2024·被引用次数：8—A total of 28 approvedanticancer peptide drugsand 80 peptides in various clinical trial stages are included in the drug library. Table 3 ...

Research highlights the growing importance of peptides in cancer therapy. For instance, studies have shown that certain peptides can suppress the growth of drug-resistant leukemia tumors in mice and demonstrate synergistic effects with existing treatments. The development of peptide-based anti-cancer therapeutics is a rapidly expanding field, with numerous peptide drug candidates undergoing preclinical and clinical evaluation.

Overcoming Challenges in Cancer Treatment

One of the most significant challenges in cancer treatment is drug resistance.作者：B Qu·2024·被引用次数：43—Anticancer peptides(ACPs) have many unique advantages compared to chemotherapydrugs, such as biocompatibility, efficient therapeutic efficacy, low risk of ... Cancer cells can evolve to become less responsive to conventional chemotherapeutic agents, leading to treatment failure and recurrence作者：AR Collins·被引用次数：1—Anticancer peptides(ACP) are small bioactivepeptides... A growing aspect in all areas of research and development especially inpeptide drug.... Anticancer peptides offer a potential solution to this problemRecent Advances in Peptide-Drug Conjugates as .... Studies have indicated that ACPs can reverse drug resistance by altering cellular processes that enable cancer cells to survive despite exposure to chemotherapy drugs. This ability to circumvent resistance mechanisms is a critical advantage of anticancer drugs based on peptides.PeptiHub: a curated repository of precisely annotated cancer ...

Beyond resistance, the detrimental side effects of conventional anticancer drugs are a major concern. Anticancer peptides often present a more favorable safety profile due to their targeted nature. While research is ongoing, early findings suggest that peptide-based drugs can offer an effective alternative to conventional chemotherapy by tackling issues like drug resistance and minimizing adverse effects.Short Peptides as Powerful Arsenal for Smart Fighting ...

The Evolving Landscape of Anticancer Peptide Drugs

The field of anticancer peptide drugs is characterized by rapid innovation and a growing number of approved and investigational therapies. Databases like DCTPep indicate a significant number of anticancer peptide drugs and peptides in various clinical trial stages. Similarly, DrugBank lists numerous peptide or polypeptide-based anticancer drugs. The United States Food and Drug Administration (FDA) has approved a growing number of peptide-based drugs for cancer therapy, underscoring their therapeutic value.

Emerging strategies include peptide-drug conjugates (PDCs), which combine the targeting capabilities of peptides with the potency of small molecule drugs. This approach aims to deliver therapeutic agents directly to cancer cells, enhancing efficacy and reducing systemic toxicity.Therapeutic peptides: current applications and future ... Another area of active investigation is the modification of existing anticancer drugs with peptides to improve their activity, selectivity, and potentially overcome multi-drug resistance.Exploring the potential of anticancer peptides as...

Future Directions and Conclusion

The journey of anticancer peptide drugs is far from over.作者：RK Chinnadurai·2023·被引用次数：119—ACPs reversedrugresistance by altering the cellular processes that allow cancer cells to survive despite exposure to chemotherapydrugs. The most effective ... Continued research into their mechanisms, design, and therapeutic applications holds immense promise for the future of cancer treatment作者：L Wang·2022·被引用次数：2125—In this article, we review the historical development ofpeptide drugsand current advances inpeptide drugdiscovery. We focus on the .... Areas such as immunomodulatory peptides and the use of artificial intelligence in discovering novel anticancer peptides are pushing the boundaries of what's possible. As our understanding deepens and technological advancements continue, anticancer peptide drugs are poised to play an increasingly vital role in the fight against cancer, offering more effective, targeted, and potentially less toxic treatment options for patients作者：QT Zhang·2021·被引用次数：65—Thepeptidemodification ofanticancer drugscould enhance their activity and selectivity, perhaps even circumventing multi-drugresistance [28] .... The ongoing exploration of novel peptide therapeutic approaches for cancer treatment signifies a new era in oncology.